This page is part of our 2021 average annual return archive: it shows the AVTE Average Annual return Since for calendar year 2021. This metric helps investors evaluate and compare performance among different stocks, over time.
Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2021 does not guarantee future similar returns.
| AVTE Average Annual Return Chart Since 2021 | |||
Also see: • AVTE stock yearly return 2022 • AVTE stock yearly return 2023 • AVTE stock yearly return 2024 • AVTE YTD return | |||
| Average Annual Return Benchmarks |
|
Compare AVTE average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| AVTE Share Performance |
| AVTE Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
AVTE average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Jade Biosciences Inc. |
| Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension (PAH), a devastating disease impacting approximately 70,000 people in the U.S. and Europe. Oral imatinib also demonstrated statistically significant improvement on the primary endpoint, six-minute walk distance, and multiple secondary hemodynamic endpoints in PAH patients. The AVTE average annual return since 2021 is shown above.
The Average Annual Return on the AVTE average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether AVTE average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the AVTE average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| AVTE Current Stock Quote |
 Free AVTE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Jade Biosciences (AVTE) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
AVTX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!